全文获取类型
收费全文 | 14614篇 |
免费 | 950篇 |
国内免费 | 92篇 |
专业分类
耳鼻咽喉 | 131篇 |
儿科学 | 318篇 |
妇产科学 | 875篇 |
基础医学 | 1863篇 |
口腔科学 | 310篇 |
临床医学 | 1648篇 |
内科学 | 3050篇 |
皮肤病学 | 276篇 |
神经病学 | 1131篇 |
特种医学 | 419篇 |
外科学 | 1975篇 |
综合类 | 281篇 |
一般理论 | 8篇 |
预防医学 | 753篇 |
眼科学 | 423篇 |
药学 | 1049篇 |
中国医学 | 125篇 |
肿瘤学 | 1021篇 |
出版年
2023年 | 56篇 |
2022年 | 44篇 |
2021年 | 311篇 |
2020年 | 154篇 |
2019年 | 308篇 |
2018年 | 413篇 |
2017年 | 251篇 |
2016年 | 280篇 |
2015年 | 441篇 |
2014年 | 534篇 |
2013年 | 750篇 |
2012年 | 1099篇 |
2011年 | 1167篇 |
2010年 | 743篇 |
2009年 | 600篇 |
2008年 | 863篇 |
2007年 | 863篇 |
2006年 | 829篇 |
2005年 | 796篇 |
2004年 | 724篇 |
2003年 | 636篇 |
2002年 | 608篇 |
2001年 | 549篇 |
2000年 | 524篇 |
1999年 | 369篇 |
1998年 | 94篇 |
1997年 | 88篇 |
1996年 | 80篇 |
1995年 | 78篇 |
1994年 | 66篇 |
1993年 | 54篇 |
1992年 | 179篇 |
1991年 | 152篇 |
1990年 | 116篇 |
1989年 | 112篇 |
1988年 | 105篇 |
1987年 | 82篇 |
1986年 | 71篇 |
1985年 | 62篇 |
1984年 | 46篇 |
1983年 | 32篇 |
1982年 | 25篇 |
1981年 | 23篇 |
1980年 | 18篇 |
1979年 | 42篇 |
1978年 | 24篇 |
1977年 | 22篇 |
1976年 | 20篇 |
1975年 | 24篇 |
1973年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
22.
23.
Chiu Hsu-Huai Hsaio Cheng-Tsung Tsai Yu-Shuen Liao Yi-Chu Lee Yi-Chung Soong Bing-Wen 《Cerebellum (London, England)》2020,19(4):544-549
The Cerebellum - Mutations in STUB1 have been identified to cause autosomal recessive spinocerebellar ataxia type 16 (SCAR16), also named as Gordon Holmes syndrome, which is characterized by... 相似文献
24.
Babiker Hani M. Milhem Mohammed Aisner Joseph Edenfield William Shepard Dale Savona Michael Iyer Swaminathan Abdelrahim Maen Beach C. L. Skikne Barry Laille Eric Tsai Kao-Tai Ho Thai 《Cancer chemotherapy and pharmacology》2020,85(3):621-626
Cancer Chemotherapy and Pharmacology - CC-486 is an oral formulation of azacitidine that allows for extended dosing schedules to prolong azacitidine exposure to malignant cells and maximize... 相似文献
25.
26.
Multidisciplinary predialysis education and team care (MDC) may slow the decline in renal function in patients with chronic kidney disease (CKD). However, associations between unexpected return during MDC and progression of renal dysfunction have not been characterized in patients with CKD. Our study aimed to determine the association between exacerbation of renal dysfunction and the frequency of unexpected return during follow-up.A total of 437 patients with CKD receiving multidisciplinary care between January 2009 and June 2013 at the Shin-Kong Wu Ho-Su Memorial Hospital were included in this retrospective observational cohort study, and multiple imputations were performed for missing data. The predictor was the frequency of unexpected return for follow-up during the first year after entering MDC. Main outcome was monthly declines in estimated glomerular filtration rates (eGFR). Moreover, the demographic data, comorbidities, history of medication, and routine laboratory data for patients with CKD were collected.Among all patients, 59.7% were male, the mean age at initiation of MDC was 69.4 ± 13.2 years, and the duration of follow-up was 21.4 ± 3.3 months. The subjects were divided into 2 groups according to frequencies of follow-up (≤4 and > 4 visits) during the 1st year of MDC. The patients with CKD were regularly followed up every 3 months as a part of MDC in our hospital, and patients who returned for more than 4 follow-up visits were included in the unexpected return group. In crude regression analyses, unexpected return was significantly associated with higher monthly declines of eGFR (β = 0.092, 95% confidence interval, 0.014–0.170). This association remained after adjustments for multiple variables, and subgroup analyses of unexpected return showed that male gender, older age, CKD stage 1 to 3, hypertension, history of coronary artery disease, and use of renin–angiotensin system blockade were significantly associated with declines in renal function.In conclusion, unexpected return for follow-up during the 1st year of MDC was significantly associated with the deterioration of renal function. 相似文献
27.
Shy-Shin Chang Chih-Cheng Lai Meng-tse Gabriel Lee Yu-Chien Lee Yi-Wen Tsai Wan-Ting Hsu Chien-Chang Lee 《Medicine》2015,94(22)
The primary objective of this study was to determine the association between the use of gastric acid suppressants (GAS) and the risk of developing spontaneous bacterial peritonitis (SBP) in patients with advanced liver cirrhosis (LC).A case–control study nested within a cohort of 480,000 representatives of Taiwan National Health Insurance beneficiaries was carried out. A case was matched with 100 controls on age, gender, and index date of SBP diagnosis. GAS use was identified from the 1-year period before the index date. Conditional logistic regression analysis was used to adjust for various unbalanced covariates between users and nonusers of GAS.A total of 947 cases of SBP were identified among the 86,418 patients with advanced LC. A significant increased risk of developing SBP was found to be associated with current (within 30 days), and recent (within 30–90 day) use of 2 different classes of GAS: proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs). The confounder adjusted rate ratio (aRR) for the current use of PPIs was 2.77 (95%CI: 1.90–4.04) and H2RAs was 2.62 (95%CI: 2.00–3.42). The risk of SBP attenuated for the recent use of PPIs (aRR: 2.20, 95%CI: 1.60–3.02) or H2RAs (aRR: 1.72, 95%CI: 1.25–2.37).In addition, sensitivity analysis using hospitalized SBP as the primary outcome showed a similar risk for the current use of PPIs (aRR, 3.24; 95%CI: 2.08–5.05) and H2RAs (aRR 2.43; 95%CI 1.71–3.46). Furthermore, higher cumulative days of gastric acid suppression were associated with a higher risk of SBP (trend P < 0.0001).To conclude, exposure to GAS was associated with an increased risk of SBP in patients with advanced LC. The association was more pronounced in current PPI users compared with nonusers. 相似文献
28.
29.